Potential role of growth hormone in impairment of insulin signaling in skeletal muscle, adipose tissue, and liver of rats chronically treated with arginine

Endocrinology

Volumn 150, Issue 5, 2009, Pages 2080-2086

  De Barbosa, Thais Castro ^a   De Carvalho, José Edgar Nicoletti ^a   Poyares, Leonice Lourenço ^a   Bordin, Silvana ^a   Machado, Ubiratan Fabres ^a   Nunes, Maria Tereza ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DRINKING WATER; GLUCOSE TRANSPORTER 4; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; JANUS KINASE 2; MESSENGER RNA; PROTEIN KINASE B; PROTEIN P55; PROTEIN P85; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, RAT; IRS2 PROTEIN, RAT; ONCOPROTEIN; SLC2A4 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DIET SUPPLEMENTATION; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HYPERINSULINEMIA; HYPOPHYSIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MALE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ADIPOSE TISSUE; ANIMAL; DOWN REGULATION; DRUG EFFECT; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TIME; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; ARGININE; DOWN-REGULATION; GLUCOSE TRANSPORTER TYPE 4; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LIVER; MALE; MUSCLE, SKELETAL; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 66449091608     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1487     Document Type: Article

References (37)

1. Morris Jr SM 2007 Arginine metabolism: boundaries of our knowledge. J Nutr 137(6 Suppl2):1602S-1609S
2. Ghigo E, Ceda GP, Valcavi R, Goffi S, Zini M, Mucci M, Valenti G, Cocchi D, Muller EE, Camanni F 1994 Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growt hhormone releasing hormone in elderly subjects. J Endocrinol Invest 17:113-117
3. Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waclawiw MA, Panza JA, Cannon RO 2000 Oral L-arginine in patients with coronary artery disease on medical management. Circulation 101:2160-2164
4. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE 1996 Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. JClin Invest 97:1989-1994
5. Adrião M, Chrisman CJ, Bielavsky M, Olinto SC, Shiraishi EM, Nunes MT 2004 Arginine increases growth hormone gene expression in rat pituitary and GH3 cells. Neuroendocrinology 79:26-33
6. Castro-Barbosa T, Lourenco-Poyares L, Fabres-Machado U, Nunes MT 2006 Chronic oral administration of arginine induces GH gene expression and insulin resistance. Life Sci 79:1444-1449
7. Alba-Roth J, Müller OA, Schopohl J, von Werder K 1988 Arginine stimulates growth hormone secretion by suppressing endogenous somatostatinse cretion. J Clin Endocrinol Metab 67:1186-1189
8. Villlalobos C, Nunez L, Garcia-Sancho J 1997 Mechanisms for stimulation of rat anterior pituitary cells by arginine and other amino acids. J Physiol 502(Pt 2):421-431
9. Bolea S, Pertusa JA, Martin F, Sanchez-Andres JV, Soria B 1997 Regulation of pancreatic β-cell electrical activity and insulin release by physiological amino acid concentrations. Pfliigers Arch 433:699-704
10. Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R 1986 Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am JPhysiol 250(3 Pt 1):E269-E273
11. Smith TR, Elmendorf JS, David TS, TurinskyJ1997 Grow thhormone induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1 and GLUT-4. Am JPhysiol 272(6 Pt 1):E1071-E1079
12. Cho Y, Ariga M, Uchijima Y, Kimura K, Rho JY, Furuhata Y, Hakuno F, Yamanouchi K, Nishihara M, Takahashi S 2006 The novel roles of liver for compensation of insulin resistance in human growth hormone transgenicrats. Endocrinology 147:5374-5384
13. Dominici FP, Cifone D, Bartke A, Turyn D 1999 Alterations in the early steps of the insulin signaling system in skeletal muscle of GH transgenic mice. Am J Physiol 277(3 Pt 1):E447-E454
14. Shepherd PR, Withers DJ, Siddle K 1998 Phosphoinositide 3-kinase: the key switch mechanism in insulin signaling. Biochem J333(Pt 3):471-490
15. Cheatham B, Kahn CR 1995 Insulin action and the insulin signaling network. Endocr Rev 16:117-142
16. Davidson MB 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131
17. Collier SR, Casey DP, Kanaley JA 2005 Growth hormone responses to varying doses of oral arginine. Growth Horm IGF Res 15:136-139
18. Wu G, Bazer FW, Cudd TA, Jobgen WS, Kim SW, Lassala A, LiP, Matis JH, Meininger CJ, Spencer TE 2007 Pharmacokinetics and safety of arginine supplementation in animals. J Nutr 137(6 Suppl 2):1673S-1680S
19. Windmueller HG, Spaeth AE1976 Metabolism ofabsorbed aspartate, aspar- agine, and arginine by rat small intestine in vivo. Arch Biochem Biophys 175: 670 -676
20. Saad MJ, Folli F, Kahn JA, Kahn CR 1993 Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 92:2065-2072
21. Araujo EP, De Souza CT, Gasparetti AL, Ueno M, Boschero AC, Saad MJ, Velloso LA 2005 Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistance, hyperinsulinemia, and increased adiposity. Endocrinology 146:1428 -1437
22. Yonemitsu S, Nishimura H, Shintani M, Inoue R, Yamamoto Y, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Hayashi T, Nakao K 2001 Troglitazone induces GLUT 4 translocation in L6 myotubes. Diabetes 50:1093-1101
23. Mori RC, Hirabara SM, Hirata AE, Okamoto MM, Machado UF 2008 Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin. Diabetes Obes Metab 10:596-600
24. Fabres-Machado U, Saito M 1995 The effect of adipose cell size on the measurement of GLUT4 in whiteadipose tissue of obesemice. Braz J Med Biol Res 28:369-376
25. White MF 1997 The insulin signalling system and the IRS proteins. Diabetologia 40(Suppl 2):S2-S17
26. Zhande R, Mitchell JJ, Wu J, SunXJ 2002 Molecular mechanism of insulin- induced degradation of insulin receptor substrate 1. Mol Cell Biol 22: 1016 -1026
27. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, Zick Y1997A molecular basis for insulin resistance: elevated serine/threonine phosphoryla- tion of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272:29911-29918
28. Herman MA, Kahn BB2006 Glucose transport andsens in ginthe main tenance of glucosehomeo stas is andmetaboli charmony. J Clin Invest 116:1767-1775
29. Kern M, Wells JA, Stephens JM, Elton CW, Friedman JE, Tapscott EB, Pekala PH, Dohm GL 1990 Insulin responsiveness in skeletal muscle is determined by glucose transporter (GLUT4) protein level. Biochem J270:397-400
30. Kimball SR, Farrell PA, Jefferson LS 2002 Role of insulin in translational control of protein synthesis in skeletal muscle by amino acids or exercise. JAppl Physiol 93:1168-1180
31. Chung HO, Kato T, Tomizawa K, Kato Y 1998 Molecular cloning of pit-1 cDNA from porcine anterior pituitary and its involvement in pituitary stimulation by growth hormone-releasing factor. Exp Clin Endocrinol Diabetes 106:203-210
32. Sugihara H, Minami S, Okada K, Kamegai J, Hasegawa O, Wakabayashi I 1993 Somatostatin reduces transcription of the growth hormone gene in rats. Endocrinology 132:1225-1229
33. del Rincon JP, Iida K, Gaylinn BD, McCurdy CE, Leitner JW, Barbour LA, Kopchick JJ, Friedman JE, Draznin B, Thorner MO 2007 Growth hormone regulation of p85a expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 56:1638-1646
34. Barbour LA, Mizanoor Rahman S, Gurevich I, Leitner JW, Fischer SJ, Roper MD, Knotts TA, Vo Y, McCurdyCE, YakarS, LeroithD, KahnCR, Cantley LC, Friedman JE, DrazninB 2005 Increased P85a is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem 280:37489-37494
35. Nielsen C, Gormsen LC, Jessen N, Pedersen SB, M0ller N, Lund S, Jergensen JO 2008 Growth hormone signaling in vivo in human muscle and adipose tissue: impactofinsulin, substrate background, and grow thhor monereceptor blockade. J Clin End ocrinol Metab 93:2842-2850
36. Chen D, Mauvais-Jarvis F, Bluher M, Fisher SJ, Jozsi A, Goodyear LJ, Ueki K, Kahn CR 2004 p50a/p55a phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol Cell Biol 24:320 -329
37. Lee YH, Giraud J, Davis RJ, White MF 2003 c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 278:2896-2902